Dr RishiRaj Sinha/LinkedIn
Nov 9, 2025, 11:29
Dr RishiRaj Sinha Highlights Ways to Participate in ISSCR 2026 Meeting
Dr RishiRaj Sinha, Member, Public Health Partnerships Subgroup Working Party at International Society of Blood Transfusion (ISBT), posted on LinkedIn:
“There are many ways to make your voice heard and participate in all that the ISSCR2026 Annual Meeting has to offer! Discover how to get involved, including submitting an abstract, proposing a science spotlight, hosting a meet-up hub, and more here!
Discover how to get involved:
- Submit an abstract and share your latest research on a global stage
- Propose a Science Spotlight or Innovation Showcase
- Host or attend a Meet-Up Hub to connect with peers and thought leaders
- Volunteer for session moderation or poster judging
- Participate in mentoring and networking sessions for early-career researchers
The International Society for Stem Cell Research Annual Meeting is the world’s leading forum for advancing the frontiers of stem cell science and regenerative medicine, connecting thousands of researchers, clinicians, policymakers, and industry experts from across the globe.”
Stay updated with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin